Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

BACKGROUND: Addition of gemcitabine and cisplatin (GP) or docetaxel and cisplatin plus fluorouracil (TPF) to concurrent chemoradiotherapy (CCRT) significantly improved survival in locoregionally advanced nasopharyngeal carcinoma (NPC). However, an economic evaluation of these regimens remains unknown...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Yang, Jiangping, Han, Jiaqi, He, Jinlan, Duan, Baofeng, Gou, Qiheng, Ai, Ping, Liu, Lei, Li, Yanchu, Ren, Kexing, Wang, Feng, Yao, Min, Chen, Nianyong
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7786365/
https://ncbi.nlm.nih.gov/pubmed/33425747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.594756
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars